These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14605321)

  • 1. Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage.
    Kay A; Petzold A; Kerr M; Keir G; Thompson E; Nicoll J
    Stroke; 2003 Dec; 34(12):e240-3. PubMed ID: 14605321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome.
    Kay A; Petzold A; Kerr M; Keir G; Thompson E; Nicoll J
    Stroke; 2003 Mar; 34(3):637-42. PubMed ID: 12624284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson E; Nicoll JA
    J Neurotrauma; 2003 Oct; 20(10):943-52. PubMed ID: 14588111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson EJ; Nicoll JA
    J Neurotrauma; 2003 Mar; 20(3):243-50. PubMed ID: 12820678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly.
    Slot RER; Kester MI; Van Harten AC; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; van der Flier WM; Veerhuis R
    Neurobiol Aging; 2019 Jul; 79():101-109. PubMed ID: 31029938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.
    Popp J; Lewczuk P; Linnebank M; Cvetanovska G; Smulders Y; Kölsch H; Frommann I; Kornhuber J; Maier W; Jessen F
    J Alzheimers Dis; 2009; 18(4):819-28. PubMed ID: 19661622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
    Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
    Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage.
    Joswig H; Korte W; Früh S; Epprecht L; Hildebrandt G; Fournier JY; Stienen MN
    Neurosurg Rev; 2018 Apr; 41(2):605-614. PubMed ID: 28890998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage.
    Kay AD; Day SP; Nicoll JA; Packard CJ; Caslake MJ
    Atherosclerosis; 2003 Sep; 170(1):141-6. PubMed ID: 12957692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
    Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
    J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
    Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
    Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.
    Ganzer S; Arlt S; Schoder V; Buhmann C; Mandelkow EM; Finckh U; Beisiegel U; Naber D; Müller-Thomsen T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1149-60. PubMed ID: 14523627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid.
    Buckley RF; Mormino EC; Chhatwal J; Schultz AP; Rabin JS; Rentz DM; Acar D; Properzi MJ; Dumurgier J; Jacobs H; Gomez-Isla T; Johnson KA; Sperling RA; Hanseeuw BJ;
    Neurobiol Aging; 2019 Jun; 78():178-185. PubMed ID: 30947113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
    Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.